Dr. Brian T. Mclaughlin

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

Vincent Edgar Reyes, Jr., MD, is the chief medical officer of the UPMC Hillman Cancer Center Medical Oncology Network and assistant clinical professor of medicine at the University of Pittsburgh School of Medicine. Dr. Reyes is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, and Lung Cancer.

William E. Spielvogle, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC Horizon. He specializes in all areas of general oncology, and has a clinical interest in breast cancer. Dr. Spielvogle is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Lynch Syndrome, and Thrombocytopenia.